The EMPOWER Trial: Evaluating a Home-Based Physical Activity Program (PAP) With the ExerciseRx™ Digital Platform vs. Health Education Group (HEG) in People With Non-Muscle Invasive Bladder Cancer

Summary

This clinical trial compares how well a home-based personalized physical activity program (PAP) that is delivered by a digital application (app) (the ExerciseRx app) works compared to health education in improving physical activity for patients with bladder cancer that has not reached the muscle wall of the bladder (non-muscle invasive). For people who are not physically active, previous studies have shown that increasing step counts can reduce incidence of death, reduce frailty, and reduce healthcare costs. The ExerciseRx app tracks adherence to home exercise, adapts step count goals based on the patient's progress, and provides encouraging feedback and motivation from the healthcare team. Additional features include activity summaries, progress towards current goal, nudges, helpful facts about the benefits of activity, and ideas for how to incorporate daily movement. A home-based PAP using the ExerciseRx app may work better in increasing physical activity among patients with non-muscle invasive bladder cancer compared to a health education only group.

Description

Eligibility

Age range

18+ years

Sex

All

Healthy volunteers

No

Interventions

• Other
  Internet-Based Intervention

  Given access to the ExerciseRx app

• Other
  Best Practice

  Given instruction to continue physical activity as usual

• Other
  Internet-Based Intervention

  Given access to the ExerciseRx app locked to the baseline home screen

• Other
  Exercise Intervention

  Complete home exercise sessions

• Other
  Health Telemonitoring

  Given a FitBit® to wear continuously

• Other
  Educational Intervention

  Given NCCN Survivorship for Healthy Living Guidelines pamphlet

• Other

Location